FDA grants approval to Natpara Purdue Pharma launches Hysingla ER IBS market to reach $1.5 billion by 2023 Boehringer Ingelheim's Spiriva Respimat now available at pharmacies Rx trends 2015: Specialty drug costs Eisai introduces savings card for weight-loss drug Belviq FDA approves Consentyx from Novartis Flu incidence on the rise along the coasts Age indication of Pediculicide Natroba (spinosad) to include children 6 months and older Supreme Court ruling protects Teva's Copaxone patent First Previous 144 145 146 147 148 Next Last
